Aspirin overutilization for the primary prevention of cardiovascular disease

JJ VanWormer, AW Miller, SH Rezkalla - Clinical epidemiology, 2014 - Taylor & Francis
Background Aspirin is commonly used for the primary prevention of cardiovascular disease
(CVD) in the US. Previous research has observed significant levels of inappropriate aspirin …

A survey of internists' recommendations for aspirin in older adults and barriers to evidence-based use

JK Schaefer, GD Barnes, JB Sussman, SD Saini… - Journal of Thrombosis …, 2022 - Springer
Recent trials suggest that aspirin for primary prevention may do more harm than good for
some, including adults over 70 years of age. We sought to assess how primary care …

Could low doses acetylsalicylic acid prevent thrombotic complications in COVID-19 patients?

F Cacciapuoti, F Cacciapuoti - Clinical and Applied …, 2021 - journals.sagepub.com
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) can induce inflammatory
and thrombotic complications of pulmonary district (interstitial pneumonia), sometimes …

An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds

MR Kolber, C Korownyk - Expert opinion on pharmacotherapy, 2014 - Taylor & Francis
Aspirin or acetylsalicylic acid (ASA) is commonly used in the general population for primary
prevention of cardiovascular disease (CVD). Strong evidence supports the use of ASA in …

Cardiovascular side effects of non-steroidal anti-inflammatory drugs in the light of recent recommendations. Diclofenac is not more dangerous

VJ Horváth, GÁ Tabák, G Szabó, Z Putz, CG Koós… - Orvosi …, 2015 - akjournals.com
Among their beneficial effects, non-steroidal anti-inflammatory drugs may also exert several
side effects which depend on the dosage and the type of these medications. The most …

Use of low-dose acetylsalicylic acid for cardiovascular disease prevention: A practical, stepwise approach for pharmacists

AR Barry, WM Semchuk, A Thompson… - … Journal/Revue des …, 2020 - journals.sagepub.com
Low-dose acetylsalicylic acid (ASA) is recommended in patients with established
cardiovascular disease. However, the role of ASA in those without cardiovascular disease …

[PDF][PDF] Pharmacokinetic evaluation of administration of losartan with aspirin in healthy volunteers

GD Mendes, PMF Ferreira… - … of Bioequivalence & …, 2015 - researchgate.net
Losartan and aspirin are often used concomitantly in patients with heart failure, ischemic
heart disease and hypertension. Objectives: To investigate whether aspirin co …

[HTML][HTML] Проблемы безопасности при использовании препаратов ацетилсалициловой кислоты для профилактики сердечно-сосудистых осложнений

ЛО Минушкина - Сердце: журнал для практикующих врачей, 2014 - lvrach.ru
Лечение низкими дозами ацетилсалициловой кислоты (АСК)(в монотерапии или в
комбинации с другими антитромбоцитарными препаратами) на сегодняшний день …

[HTML][HTML] Некоторые вопросы назначения ацетилсалициловой кислоты в клинической практике

ЯА Орлова - Артериальная гипертензия, 2015 - cyberleninka.ru
Данная статья посвящена долгосрочному назначению ацетилсалициловой кислоты
(АСК) для первичной и вторичной профилактики сердечно-сосудистых заболеваний …

Should aspirin be used for the primary prevention of cardiovascular disease in the general population?

QY Huang, RQ Yang - Medical Principles and Practice, 2015 - karger.com
1 Evans G, Packham MA, Nishizawa EE: The effect of acetylsalicylic acid on platelet
function. J Exp Med 1968; 128: 877–894. 2 Ajani UA, Ford ES, Greenland KJ, et al: Aspirin …